baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out BMY/ DE000VV39WQ5 /

24/06/2024 21:41:34	Chg.-0.05	Bid22:00:39	Ask22:00:39	Underlying	Strike price	Expiration date	Option type
4.78EUR	-1.04%	- Bid Size: -	- Ask Size: -	Bristol Myers Squibb...	93.48 USD	31/12/2078	Put

GlobeNewswire 19/06 Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Re...

GlobeNewswire 19/06 CSE is hosting in New York City the Sustainability & ESG Leadership Summit

GlobeNewswire 18/06 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...

GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire 17/06 Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increa...

GlobeNewswire 17/06 Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angel...

GlobeNewswire 14/06 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...

GlobeNewswire 12/06 Crossject appoints Dan Chiche, MD as Chief Medical Officer North America

GlobeNewswire 11/06 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors

GlobeNewswire 11/06 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...

GlobeNewswire 11/06 Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001

GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

GlobeNewswire 10/06 C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors

GlobeNewswire 31/05 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...

GlobeNewswire 30/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...

GlobeNewswire 24/05 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board

GlobeNewswire 23/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...

GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...

GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 22/05 Anavex Life Sciences Announces Expansion of Leadership Team

GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants

GlobeNewswire 15/05 Lantheus Announces Executive Appointments to Accelerate Innovation

GlobeNewswire 14/05 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...

GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...

GlobeNewswire 13/05 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update

BVT Knock-Out BMY/ DE000VV39WQ5 /

If you wish to receive reply to your feedback, please provide your email address.